Valuation: Bayer AG

Market Cap 47.11B 53.49B 44.63B 40.29B 75.94B 5,129B 76.93B 534B 205B 2,622B 201B 196B 8,407B P/E 2026 *
21.7x
P/E 2027 * 15.6x
Enterprise Value 77.06B 87.51B 73.02B 65.92B 124B 8,391B 126B 874B 336B 4,290B 329B 321B 13,753B EV / Sales 2026 *
1.68x
EV / Sales 2027 * 1.57x
Free-Float
99.99%
Yield 2026 *
0.33%
Yield 2027 * 1.16%
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 61 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.38% - - 53.49B
-2.33%+0.53%+51.65%+115.42% 1,031B
-1.06%-1.65%+42.78%+69.98% 638B
-0.65%-1.32%+12.98%+75.49% 462B
-2.66%-1.87%+73.13%+41.15% 359B
-0.26%-4.24%+23.27%+40.29% 335B
-1.37%-0.61%+13.67%+26.64% 273B
-1.23%-2.21%-2.49%+10.74% 253B
-0.50%+3.80%+49.37%+56.84% 228B
-1.47%-1.53%+34.28%+98.89% 185B
Average -3.02%-0.36%+33.18%+59.49% 418.21B
Weighted average by Cap. -1.37%-0.35%+37.53%+71.22%

Financials

2026 *2027 *
Net sales 45.83B 52.04B 43.42B 39.2B 73.89B 4,990B 74.84B 520B 200B 2,551B 195B 191B 8,179B 47.06B 53.44B 44.59B 40.25B 75.87B 5,124B 76.85B 533B 205B 2,620B 201B 196B 8,399B
Net income 2.14B 2.43B 2.03B 1.83B 3.45B 233B 3.49B 24.26B 9.34B 119B 9.13B 8.93B 382B 2.94B 3.34B 2.79B 2.51B 4.74B 320B 4.8B 33.33B 12.83B 164B 12.54B 12.26B 525B
Net Debt 29.96B 34.02B 28.38B 25.62B 48.29B 3,262B 48.92B 340B 131B 1,667B 128B 125B 5,346B 26.84B 30.48B 25.43B 22.96B 43.27B 2,922B 43.83B 304B 117B 1,494B 114B 112B 4,789B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.95EUR
Average target price
58.22EUR
Spread / Average Target
+21.42%

Quarterly revenue - Rate of surprise